Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWKVP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,955
Award facts
- Contract value 100% obligated
- $16,955.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price arrangement. The award, issued on September 23, 2025, carries a ceiling value of $16,955.15 with an ultimate completion date of September 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio with the Defense Logistics Agency focused on delivering brand-name and generic medications across multiple therapeutic domains to military and veteran healthcare systems. The company's competitive awards history and extensive experience fulfilling federal medical procurement requirements demonstrate its capability to serve as a critical vendor for the Defense Health Agency and other government healthcare entities. This delivery order for Otezla, a treatment used in rheumatologic conditions, exemplifies the type of pharmaceutical commodities routinely supplied through the company's primary vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DB25FWKVP?
SPE2DB25FWKVP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FWKVP worth?
The government has obligated $16,955 on SPE2DB25FWKVP.
Is contract SPE2DB25FWKVP an order under another contract?
Yes. SPE2DB25FWKVP is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKVP competed?
The extent of competition for SPE2DB25FWKVP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award